The Size of the ureteral Stents Market in the Asia Pacific was valued at USD 84.67 Million in 2021 and is poised to reach USD 131.37 Million by 2026, to grow at a CAGR of 9.18% during the forecast period 2021 to 2026.
Due to the rising prevalence of urological disorders, government measures to strengthen the healthcare system, and increased disposable money among the middle-class population, Asia Pacific offers significant potential. A ureteral stent is a small hollow tube put into the ureter to relieve blockages in the urine flow of the kidney. Urolithiasis (kidney and ureteral stones) and urine incontinence are becoming more common around the region due to many reasons, such as increased calcium in the diet, alcohol consumption, and unhealthy lifestyles.
Ureteroscopy and ureterorenoscopy, among other things, need a ureteral stent to treat kidney stones, which is driving the market. Negative lifestyle behaviors such as alcohol consumption and an increase in the number of smokers and an obese population with dietary abnormalities are a few of the variables that contribute to such disorders or conditions. After the kidney transplant, a ureteral stent is implanted in the patient's body for a few days to allow the newly transplanted kidney to acclimatize to the patient's body.
The demand for ureteral stents has increased due to the rising number of kidney transplants and issues with renal dysfunction. It is expected to fuel the market for ureteral stents during the next few years. Furthermore, increased kidney transplants, the geriatric population, and developments in stent composition materials are projected to drive market growth. Due to a higher frequency of urinary tract infections and higher adoption of ureteral stents, the urinary tract infection segment is expected to grow significantly in the ureteral stents market.
The market's expansion is restricted by a shortage of experienced specialists and the adverse side effects connected with the usage of ureteral stents.
This research report on the Asia Pacific Ureteral Stents Market has been segmented and sub-segmented into the following categories
By Type:
By Patients Sex:
By End User:
By Medical Situation:
By Country:
Geographically, Asia Pacific is expected to have the highest CAGR among others. A high aging population with kidney-related disorders, increased urological procedures, and improving healthcare infrastructure in this nation are all driving the market. Furthermore, the expanding medical tourism industry in developing countries such as India, China, and Japan is expected to boost market growth.
In addition, increased government healthcare spending, increased number of hospitalizations, enhanced reimbursement scenarios, and low ureteral stent manufacturing costs are a few other factors supporting the market's expansion in this area. Furthermore, factors driving the adoption of ureteral stents technology include an increase in the incidence of urological diseases caused by microorganism colonization or a sedentary lifestyle, an increase in the geriatric population, and technological advancements in stent composition materials.
In addition, more effective and better outcomes for urinary and renal problems have resulted from technological developments in ureteral stents due to biodegradable polymers. Furthermore, throughout the operation, leading companies are focused on lowering stent migration, ureterovesical reflux, and tissue irritation, which is expected to boost the market growth.
KEY MARKET PLAYERS
Top Companies leading the Asia Pacific Ureteral Stents Market Profiled in the Report are UteraC. R. Bard, Inc., Penn Medical, Cook Medical Inc., Boston Scientific Corporation and Medline Industries, Inc.,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Patient's Sex
5.1.1 Introduction
5.1.2 Female
5.1.3 Male
5.1.4 Y-o-Y Growth Analysis, By Patient's Sex
5.1.5 Market Attractiveness Analysis, By Patient's Sex
5.1.6 Market Share Analysis, By Patient's Sex
5.2 Type
5.2.1 Introduction
5.2.2 Expandable Stent
5.2.3 Double pigtail stent (JJ Stent)
5.2.4 Others
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Medical Situation
5.3.1 Introduction
5.3.2 Kidney Failure
5.3.3 Kidney Stones
5.3.3.1 Ureteroscopy
5.3.3.2 Ureteroenoscopy
5.3.4 Tumors
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By Medical Situation
5.3.7 Market Attractiveness Analysis, By Medical Situation
5.3.8 Market Share Analysis, By Medical Situation
5.4 End-User
5.4.1 Introduction
5.4.2 Hospital
5.4.3 Clinical
5.4.4 Y-o-Y Growth Analysis, By End User
5.4.5 Market Attractiveness Analysis, By End User
5.4.5 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Patient's Sex
6.1.3.3 By Type
6.1.3.4 By Medical Situation
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Patient's Sex
6.1.4.3 By Type
6.1.4.4 By Medical Situation
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Patient's Sex
6.1.5.3 By Type
6.1.5.4 By Medical Situation
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Boston Scientific Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cook Medical Inc.
8.3 C. R. Bard, Inc.
8.4 Medline Industries, Inc.
8.5 Pnn Medical
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
